A detailed history of Clifford Swan Investment Counsel LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Clifford Swan Investment Counsel LLC holds 254,425 shares of EW stock, worth $17.2 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares
254,425
Previous 239,391 6.28%
Holding current value
$17.2 Million
Previous $22.1 Million 24.07%
% of portfolio
0.6%
Previous 0.83%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$59.7 - $93.78 $897,529 - $1.41 Million
15,034 Added 6.28%
254,425 $16.8 Million
Q2 2024

Aug 06, 2024

SELL
$84.3 - $94.31 $51,507 - $57,623
-611 Reduced 0.25%
239,391 $22.1 Million
Q1 2024

Apr 16, 2024

SELL
$72.54 - $95.56 $961,880 - $1.27 Million
-13,260 Reduced 5.24%
240,002 $22.9 Million
Q4 2023

Feb 06, 2024

SELL
$61.71 - $77.76 $65,227 - $82,192
-1,057 Reduced 0.42%
253,262 $19.3 Million
Q3 2023

Nov 09, 2023

SELL
$69.28 - $93.38 $84,590 - $114,016
-1,221 Reduced 0.48%
254,319 $17.6 Million
Q2 2023

Aug 03, 2023

SELL
$81.41 - $94.33 $21,329 - $24,714
-262 Reduced 0.1%
255,540 $24.1 Million
Q1 2023

May 05, 2023

SELL
$74.26 - $84.51 $37,501 - $42,677
-505 Reduced 0.2%
255,802 $21.2 Million
Q4 2022

Feb 02, 2023

SELL
$68.3 - $87.44 $372,303 - $476,635
-5,451 Reduced 2.08%
256,307 $19.1 Million
Q3 2022

Nov 04, 2022

SELL
$82.37 - $107.29 $382,361 - $498,040
-4,642 Reduced 1.74%
261,758 $21.6 Million
Q2 2022

Aug 04, 2022

SELL
$86.5 - $128.27 $90,911 - $134,811
-1,051 Reduced 0.39%
266,400 $25.3 Million
Q1 2022

May 03, 2022

SELL
$101.96 - $128.34 $1.01 Million - $1.28 Million
-9,944 Reduced 3.58%
267,451 $31.5 Million
Q4 2021

Feb 11, 2022

SELL
$106.37 - $130.68 $344,532 - $423,272
-3,239 Reduced 1.15%
277,395 $35.9 Million
Q3 2021

Nov 02, 2021

SELL
$102.91 - $122.75 $787,776 - $939,651
-7,655 Reduced 2.66%
280,634 $31.8 Million
Q2 2021

Aug 05, 2021

SELL
$83.84 - $104.76 $374,764 - $468,277
-4,470 Reduced 1.53%
288,289 $33 Million
Q1 2021

May 07, 2021

SELL
$78.68 - $90.67 $373,257 - $430,138
-4,744 Reduced 1.59%
292,759 $24.5 Million
Q4 2020

Feb 11, 2021

SELL
$71.69 - $91.23 $904,369 - $1.15 Million
-12,615 Reduced 4.07%
297,503 $27.1 Million
Q3 2020

Oct 30, 2020

SELL
$67.19 - $87.44 $87,750 - $114,196
-1,306 Reduced 0.42%
310,118 $24.8 Million
Q2 2020

Aug 06, 2020

BUY
$57.54 - $76.95 $11.9 Million - $15.9 Million
206,608 Added 197.11%
311,424 $21.5 Million
Q1 2020

Apr 09, 2020

SELL
$52.41 - $81.0 $56,026 - $86,589
-1,069 Reduced 1.01%
104,816 $19.8 Million
Q4 2019

Jan 30, 2020

SELL
$71.7 - $82.09 $285,150 - $326,471
-3,977 Reduced 3.62%
105,885 $24.7 Million
Q3 2019

Nov 12, 2019

SELL
$61.55 - $75.43 $86,600 - $106,130
-1,407 Reduced 1.26%
109,862 $24.2 Million
Q2 2019

Aug 13, 2019

SELL
$55.74 - $64.41 $47,434 - $54,812
-851 Reduced 0.76%
111,269 $20.6 Million
Q1 2019

May 14, 2019

SELL
$47.89 - $64.05 $52,726 - $70,519
-1,101 Reduced 0.97%
112,120 $21.5 Million
Q4 2018

Feb 13, 2019

SELL
$46.41 - $56.94 $72,863 - $89,395
-1,570 Reduced 1.37%
113,221 $17.3 Million
Q3 2018

Nov 14, 2018

SELL
$45.7 - $58.03 $34,960 - $44,392
-765 Reduced 0.66%
114,791 $20 Million
Q2 2018

Aug 13, 2018

SELL
$42.45 - $51.3 $36,973 - $44,682
-871 Reduced 0.75%
115,556 $16.8 Million
Q1 2018

May 09, 2018

SELL
$37.19 - $47.45 $60,061 - $76,631
-1,615 Reduced 1.37%
116,427 $16.2 Million
Q4 2017

Feb 09, 2018

BUY
$33.79 - $39.39 $4,933 - $5,750
146 Added 0.12%
118,042 $13.3 Million
Q3 2017

Nov 13, 2017

SELL
$36.29 - $38.83 $46,814 - $50,090
-1,290 Reduced 1.08%
117,896 $12.9 Million
Q2 2017

Aug 11, 2017

BUY
N/A
119,186
119,186 $14.1 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Clifford Swan Investment Counsel LLC Portfolio

Follow Clifford Swan Investment Counsel LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clifford Swan Investment Counsel LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clifford Swan Investment Counsel LLC with notifications on news.